INSTRUCTIONS Managing sexually transmitted infections: Beyond the 2015 guidelines
- To take the test online, go to our secure website at www.nursingcenter.com/ce/NP. View instructions for taking the test online there.
- If you prefer to submit your test by mail, record your answers in the test answer section of the CE enrollment form on page 35. You may make copies of the form.
- Each question has only one correct answer. There is no minimum passing score required.
- Complete the registration information and course evaluation. Mail the completed form and registration fee of $17.95 to: Lippincott Professional Development CE Group, 74 Brick Blvd., Bldg. 4, Suite 206, Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form. You will receive your CE certificate of earned contact hours and an answer key to review your results.
- Registration deadline is June 5, 2020.
DISCOUNTS and CUSTOMER SERVICE
- Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together and deduct $0.95 from the price of each test.
- We also offer CE accounts for hospitals and other healthcare facilities on nursingcenter.com. Call 1-800-787-8985 for details.
Lippincott Professional Development will award 1.5 contact hours for this continuing nursing education activity.
Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.5 contact hours. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, and Florida CE Broker #50-1223.
This activity has been assigned 1.0 pharmacology credits.
Managing sexually transmitted infections: Beyond the 2015 guidelines
General Purpose: To provide information about the risks and types of STIs and updated guidelines for their diagnosis and management. Learning Objectives/Outcomes: After completing this continuing-education activity, you should be able to: 1. Review STI prevention, screening, and types of viral and bacterial STIs. 2. Outline the updated guidelines for the treatment and management of STIs.
- Which of the following statements below is accurate regarding STIs?
- CDC guidelines are based on race, ethnicity, gender, and sexual preference.
- HPV is the most common STI in men.
- Older adults are among the populations most burdened by STIs.
- Which statement about HPV genotypes is accurate?
- Genotype 6 is a high-risk genotype.
- Genotype 11 is a high risk for cervical and penile cancer.
- Genotypes 18 and 16 cause most cervical, vaginal, and oropharyngeal cancers.
- Trials using PrEP for HIV have shown that the risk of
- severe neurologic manifestations were lowered.
- HIV transmission during sex is lowered.
- a secondary infection with hepatitis A is lowered.
- HIV seroadaptive strategies include all of the following except
- limiting anal sex without a condom to partners with a similar HIV status.
- having a non-HIV-infected partner act as a receptive partner for anal intercourse.
- using a condom only with HIV serodiscordant partners.
- Annual hepatitis C screening and diagnostic testing with assays is recommended for
- MSM with HIV.
- men who do not use condoms and are sexually active.
- men who engage in heterosexual anal sex.
- Zika virus infections
- always initially present with high fever and neurologic symptoms.
- manifest as Guillain-Barré syndrome in infected infants.
- can cause microcephaly in infants of infected mothers.
- Concerning the sexual transmission of the Zika virus,
- contagiousness may exceed 1 month after onset of symptoms.
- transmission is most commonly from symptomatic females to male partners.
- males should use condoms for up to 1 year after onset of symptoms.
- Regarding the Zika virus,
- transmission via breastfeeding has been confirmed in several studies.
- lab tests are now widely available for diagnosis.
- screening is not recommended to determine the presence of the virus.
- Which of the following groups is considered high risk and should be screened for chlamydia and gonorrhea?
- women who are pregnant or breastfeeding
- sexually active male adolescents ages 15-19 years
- sexually active women under the age of 25 years
- When a patient has a diagnosis of syphilis, the NP should
- prescribe a fluoroquinolone.
- test for hepatitis C.
- prescribe penicillin G benzathine.
- Trichomonas vaginalis
- is a fungal infection.
- should be routinely screened in women with syphilis infection.
- infection with a positive NAAT test should be retested after treatment.
- Which statement about M. genitalium is accurate?
- If left untreated, it can cause Guillain-Barré syndrome.
- Common symptoms in men are urethritis and penile discharge.
- Women with this infection have three times the risk of developing syphilis.
- In order to specifically diagnose M. genitalium, which test(s) should be ordered?
- urine culture and sensitivity
- NAAT testing
- blood culture and sensitivity
- When treating an adolescent for an STI,
- parents must accompany the adolescent for STI treatment.
- parental consent must be obtained to treat the STI.
- parental consent is not needed to treat an STI.
- Because older adults are at risk for STIs, the NP should
- educate older adults about condom use and biologic risk factors for STIs.
- routinely screen all adults over 65 years for HIV.
- limit screening because HIV rates have declined in older adults.
- If a patient is a transgender woman, keep in mind that this individual
- was born with male anatomy but identifies as a woman.
- was born with female anatomy but identifies as a man.
- has the genitalia of both genders.
- Which immunizations are currently available?
- syphilis, gonorrhea, and HPV
- hepatitis A, hepatitis B, and HPV
- hepatitis A, HPV, and T. vaginalis